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Abstract 
 
During late summer and autumn 2008 the Norwegian Veterinary Institute Bergen received 
several diagnostic cases with similar histopathological changes. Due to unknown cause of the 
the condition it was subsequently called “autumn disease”. Later on the microsporidian 
Desmozoon lepeophtherii was proposed associated with the autumn disease. D. lepeophtherii 
was also suggested associated with the development of pancreas disease (PD), heart and 
skeletal muscle inflammation (HSMI), cardiomyopathy syndrome (CMS) and proliferative 
gill inflammation (PGI) in farmed Atlantic salmon. 
In this study real time PCR and calcofluor white stain were used to detect D. lepeophtherii in 
formalin fixed paraffin embedded organ tissue used for diagnostic purposes. This was 
material and fish samples officially diagnosed with PD, HSMI, CMS and PGI in addition to 
autumn disease. The material was collected at the Veterinary Institute in Bergen from the 
years 2005, 2008 and 2009, and from the Veterinary Institute in Harstad year 2009. The main 
purpose of the study was to examine the presence of D. lepeophtherii in the diagnostic 
material and to evaluate a possible association between the microsporidian and any of these 
diseases.   
The results of the study showed no association between D. lepeophtherii and the diseases PD, 
HSMI and CMS. The results showed, however, an increased D. lepeophtherii burden in PGI 
samples and in the 2008 autumn disease individuals in material from Southern Norway. The 
results therefore indicate a possible association for D. lepeophtherii to the conditions autumn 
disease and PGI in farmed salmon from Southern Norway. In the material from Northern 
Norway the D. lepeophtherii burden was very low. In this material D. lepeophtherii was not 
associated with any disease condition. 
The study also showed that stored formalin fixed paraffin embedded material is very adequate 
for this type of work. The Norwegian Veterinary Institute has a large amount of historical 
diagnostic material that can be used for further studies on different disease conditions. 
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Introduction 
 
 
The “autumn disease” 
 
During fall 2008, the Norwegian Veterinary Institute (NVI) received several diagnostic 
samples of Atlantic salmon (Salmo salar) with shared diagnostic features. The samples were 
investigated for bacterial or viral causative agents with negative result. Altogether there were 
cases from 25 locations with similar clinical, macro- and histopathological findings. The 
locations were scattered from Rogaland to Møre and Romsdal. Up to 20 per cent mortalities 
in addition to reduced growth were registered at some locations.  
 
 
Figure 1 - Map showing locations with diagnosed autumn disease in September 2008 (green), October 2008 
(blue), and January 2009 (red). Photo: Epidemiological unit, The Norwegian Veterinary Institute.  
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Clinical signs commonly reported for affected salmon were respiratory problems. 
Predominant autopsy findings were usually dilated operculum, swollen and pale gills, ascites, 
yellowish liver, swollen, dark spleen, and petecchial bleedings in perivisceral adipose tissue. 
Generally the fish also had lack of gut contents. Histological examination revealed epithelial 
proliferation, necroses and circulatory disturbances in the gills. Some fish also had renal 
interstitial bleeding, inflammation cell infiltration, hyperplasia of Bowman’s capsule, 
peritonitis, hemosiderosis and steatitis.   
 Due to unknown cause of the condition and epidemic occurrence during autumn, the disease 
was called ”autumn disease” 72. Recent studies indicate that a microsporidian hyperparasite, 
Desmozoon lepeophtherii 21 (also called Paranucleospora theridion) 56,  may be associated 
with “autumn disease”. Recently it has been suggested that this microsporidian parasite is 
connected with other diseases that occur in the farmed Atlantic salmon industry 50,51,53,56.The 
diseases suggested associated with D. lepeophtherii are pancreas disease (PD), proliferative 
gill inflammation (PGI), cardiomyopathy syndrome (CMS), and heart and skeletal muscle 
inflammation (HSMI).   
  
General features of the microsporidia 
 
The microsporidia were discovered 150 years ago. The first microsporidium described was 
Nosema bomicis, a parasite of silkworms 48. Sprague et al., 1992, described in their report 
more than 1200 species in phylum Microsporidia 68. Later on several additional species have 
been added. Microsporidians are best known as parasites of insects, but they are also 
responsible for infections in crustaceans, fish and mammals.  The first disease caused by a 
microsporidian parasite recognized in vertebrates was infection by Glugea anomala in 
threespined sticklebacks (Gasterosteus aculeatus) 40. There are more than 156 microsporidian 
species distributed in 14 genera 41 infecting fish. The end stage of the microsporidian life 
cycle is the creation of mature spores. The spore stage has several structures characteristic for 
the microsporidia, and is very suited for transmission. 
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The microsporidian life cycle 
 
Microsporidia are fungi like, eukaryotic, obligate intracellular, spore forming parasites. They 
parasitize on a wide range of both vertebrate and invertebrate hosts, including humans. They 
lack mitochondria 26, and are dependent on one or several hosts to reproduce and carry out 
their lifecycle. Microsporidia were earlier suggested as primitive eukaryotes, but recent 
studies have shown that they are highly specialized eukaryotes that have gone through a 
reductive development for adaptation to an obligate intracellular life 31. The microsporidia are 
now classified as fungi 75.  
 
Microsporidian life cycles and transmission strategies are known as some of the most 
complex known among parasites. The strategies include use of direct and indirect life cycles, 
with both horizontal and vertical transmission 14. The general transmission route is, however, 
horizontal transmission. The parasite can be transmitted sexually, orally or by direct invasion 
through the host epithelium. Infective spores enter the host and may further on spread to host 
target tissue and cells 13. Microsporidia produce highly environmentally resistant spores with 
unique ultra-structural characters, which can survive outside the host cell for a long period of 
time (Fig. 2).  
 
There are three distinct phases in the development of microsporidia.  
1. The environmental infective phase with the mature spore. 
2. The proliferative phase with merogeny that accumulate number of spores. 
3. The sporogonic phase with sporogeny. Sporonts produce sporoblasts that further 
develop into mature spores 5. 
 
The spore size varies from 1 to 40µm, and the shape in most species is oval or pyriform, but 
other shapes are not unusual 73. The two major parts of the spore wall is the exospore and the 
endospore. The external proteinaceous electron dense layer, the exospore, is about 10 – 200 
nm thick depending on the genera 39. The endospore layer consists mainly of chitin and 
protein layers below the outer exospore, and can be up to 100 nm thick 15,73. The spore wall is 
also the site of active and passive transport of solutions, and acts as a pressure vessel during 
germination 24. A cell membrane separate the spore wall from the spore cytoplasm, also called 
sporoplasm. This contains either one individual nucleus (monokaryon) or two associated 
nuclei (diplokaryon) 73. The cytoplasm possesses free ribosomes of a prokaryotic type with a 
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70S unit that dissociates into 50S and 30S subunits containing 23S RNA and 16S RNA, 
respectively, and they lack a separate 5.8S RNA 12,29,76. The unique infectious apparatous: the 
polaroplast, the polar filament (or the polar tube), and the posterior vacuole are the three 
fundamental structures that are related to microsporidian infection. The polaroplast lies in the 
anterior region of the spore and contains several lamellar membranes. A hollow structure 
known as the polar tube; is connected to the top of the spore by an anchoring disc. This tube is 
arranged in helical coils down from the anchoring disk to the posterior part of the spore. 
Number of coils vary among the different species, and the tube vary in length from 50- 
500µm 32. During germination, the polar tube turns inside out of the spore, and forms a canal 
by which the infective sporoplasm can reach new host cells. At the posterior part of the spore, 
there is a clear membrane bound area, also called the posterior vacuole. This is a membrane-
bound organelle which swells just before germination 5. It is suggested that chemical stimulus 
such as pH and cations in the host trigger the coiled polar tube to elongate and germinate 25,71, 
forming a hollow tube that can infect the host cell. The posterior vacuole expands during the 
germination and pushes the infective spore content into the polar tube and further into the host 
cell cytoplasm.73. After the discharge of the sporoplasm, only the spore wall, plasma 
membrane, and some membrane profiles remain in the previous spore, forming a “spore 
ghost” 78.  
 
 
Figure 2 - Diagram of a generalized 
microsporidian spore. Spore wall containing 
three layers: 1 exospore, 2 endospore and 3 
inner plasma membrane, 4 monokaryon 
nucleus (some microsporidia have diplokarya 
nuclei), 5 polaroplast, 6 polar tube, 7 
anchoring disk and 8 posterior vacuole. 
(Figure modified from figure in chapter 3; 
kompendium i fiskesydommer”) 30.  
 
 
 
 
Once the sporoplasm reaches the host 
cell cytoplasm, the parasite is referred 
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to as a meront. This is the proliferative phase (merogeny). These cells have a round shape and 
are surrounded by a unit membrane 73. The meront cytoplasm contains either one single 
nucleus or a double nucleus depending on the species. The cytoplasm also contains a poorly 
developed endoplasmatic reticulum and many free ribosomes 6.  Microsporidia can divide in 
three different ways: either binary fission, plasmotomy or multiple budding. 
 
The ultrastructural evidence that the parasite has entered the final sporoginal phase of 
reproduction is when an electron dense material are deposited on the outer plasmamembran of 
the meront 5,73. They are now classified as sporonts, the initial stage of sporogeny. Sporonts 
undergo further division, and become sporoblasts, the products of the last cell division. This is 
the last stage of the intracellular host cell dependent development, resulting in fully matured 
microsporidian spores 11.  
 
Host- parasite relationships of fish microsporidia can be divided into two different groups 67. 
The one that does not form xenoma (e.g., Nucleospora and Pleistophora), and those forming 
xenoma (e.g., Glugea, Loma and Tetramicra). The term “xenoma” represents a highly 
hypertrophic host cell that contains multiple spores and developmental stages of the 
microsporidian. The hypertrophied cells can develop into large, white macroscopically visible 
cysts, measuring up to 500 µm 43,62.    
 
Desmozoon lepeophtherii 
 
Mark Freeman discovered in 2002 a previously unknown hyperparasitic microsporidium 
infecting the salmon louse Lepeopthteirus salmonis 19. The main goal of his study was to 
detect any L. salmonis specific pathogens with a potential as biological control agents against 
the salmon louse. He sampled sea lice from 15 farm sites in Scotland, and discovered lice 
heavily infected with an unidentified microsporidium. Using transmission electron 
microscopy (TEM) he discovered cysts containing spore-like structures distributed within the 
haemocoel of the salmon lice. TEM results showed the infection in the louse to be associated 
with epidermal cells beneath the cuticula (Fig. 3). Based on rDNA Freeman placed the 
discovered microsporidianum in the phylogenetic clade Enterocytozoonidae with the genera 
Nucleospora and Enterocytozoon 20. Based on target cells (desmocytes) and host name the 
microsporidium was given the name Desmozoon lepeophtherii 21. As part of the work to 
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characterize the life cycle of D. lepeophtherii Atlantic salmon was screened for the 
microsporidium. Using PCR Freeman found salmon testing positive for the parasite19. DNA 
that was isolated from infected salmon lice and positive Atlantic salmon, where compared, 
and were found to come from the same species. He therefore suggested the microsporidium to 
be transmitted between Atlantic salmon and sea louse. The life cycle was later further 
described by Nylund et al., after identifying it in Norwegian Atlantic salmon and in salmon 
louse (L. salmonis) in 2008. It was then named Paranucleospora theridion by Nylund et al., 
2010 56. Molecular rDNA studies have found the rDNA small subunit to be identical between 
the Scottish and Norwegian isolates, suggesting them to be the same species (SSU; GenBank 
accession no: AJ 431366) 55. D. lepeophtherii  has also been found in the sea louse (Caligus 
elongatus), in sea trout (Salmo trutta) and in rainbow trout (Oncorhynchus mykiss) 56. From 
the ultrastructural and development examinations performed in Norway by Nylund et al., 
2010 56, it is proposed that the microsporidium has a very complex life cycle (Fig 4). The 
Atlantic salmon acts in this case as the intermediate host, while the copepod L.  salmonis is 
defined as the main host. Real time PCR results have shown the microsporidium to be present 
in all developmental stages of L. salmonis 56 and C. elongatus.  The development of the 
microsporidium in salmon occurs in two different cycles. The first cycle occurs in the 
cytoplasm of several cell types. These cells include macrophage like cells, blood vessel 
endothelial cells, polymorphonucleate leucocytes in the host tissue and also the gill epithelial 
cells and skin cells 56. Spores developed in this first cycle are approximately 0,8-1,8 µm in 
diameter, have a thin spore wall and a short polar tube, and are referred to as auto infective 
spores. In development cycle two there is a production of ellipsoidal environmental spores 
with a thick endospore wall and thin exospore wall. The polar tube from this spore is longer 
than the polar tube found in the auto infective spores, and is only found within the nucleus of 
the epithelial cells of the fish gill and skin. Mature spore size is about 2,4 -2,7 µm long × 2-0 -
2,1 µm wide 56. It is shown that the infected cells contain one or more spores in each nucleus.   
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Figure 3 -Transverse semi-thin section through the abdomen of an infected adult female of L. salmonis. Xenoma 
(*) developing between the cuticle (c) and the gut (g). (Bar= 100 µm). 
 
 
Salmon lice that feed on an infected fish receive the microsporidian spores through its 
ingestion of fish mucus, blood and epithelial cells. This is assumed to be the transmission 
route between the intermediate host and main host. The development within L. salmonis 
results in two different types of spores, macro- and microspores. The purpose of the 
macrospores is so far unknown. Microspores are spherical. Infection by the microsporidium 
occurs in the glycocalyx border that lies beneath the cuticle. Cells often infected are epithelial 
cells, connective tissue, desmocytes, satellite cells and haemocytes. Spore development is in 
direct contact with the cell cytoplasma the entire time of the development cycle. Growth of 
the parasite within these cells results in massive host cell hyperthrophy and large xenoma-like 
cysts that forms directly under the cuticle (Fig. 3) which contains large numbers of different 
development stages of D. lepeophtherii 20,56. Spores can then be released from these into the 
sea water. Free spores are spread horizontally through the water. Infection of the salmonid 
host is believed to occur through the gills. 
 
 
 
Freeman et al., 2003 
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Lifecycle of Desmozoon lepeophtherii 
 
 
 
 
 
Figure 4 –Lifecycle of D. lepeophtheri. Spore formation occurs in both salmon lice and salmonids. Mature 
spores are taken up through the fish gills. In salmon two types of spores develop (autoinfective spores and 
environmental spores). These spores are trensferred to salmon lice when they eat the skin epithelial cells and 
blood of the salmon. Spore formation in salmon lice occurs directly beneath the cuticle, and the spores are spread 
further to the water. (Figures obtained and modified from www.genok.no and Schram 1993) 65. 
 
Pancreas disease (PD) 
 
Pancreas disease (PD) is a severe viral fish disease with major influence in salmonid fish 
farms and aquaculture. PD was first detected and described in Scotland in 1976 46. The 
disease has later been described in countries like Ireland 47 and Norway 60. In 1995 an 
alphavirus (Salmonid alphavirus or SAV) was reported to be the causative agent of the 
disease 49. Clinical signs of PD are often sudden drop of appetite and abnormal swimming 
behaviour near the water surface. The disease leads to great economical losses in the industry 
due to both mortality and reduced growth. Reduced growth is associated with pancreatic 
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tissue damage 46,70. Histopathological findings in affected fish are necrosis and loss of 
exocrine pancreas, necrosis and inflammation in heart muscle ventricle and inflammation and 
degeneration in red and white skeletal muscle 44,70. The causative virus of PD is divided into 
six subtypes (SAV 1, 2, 3, 4, 5 and 6) based on phylogenetic studies 22. The subtypes show 
geographical separations in Europe, and SAV3 (Norwegian salmonid alphavirus, NSAV) is 
the only type seen in Norway 28.  Since the mid-1990s PD has been diagnosed yearly in 
Norway. The number of recorded cases was low in the period 1998-2002, but increased 
drastically until 2008 7 with the number of affected locations remaining high. The diagnostic 
criteria for PD are based on histological examinations and detection of virus. 
 
 
Heart and skeletal muscle inflammation (HSMI) 
 
A new disease was discovered in farmed Atlantic salmon in Norway in1999 36. The disease 
was also reported from the United Kingdom 16. Several farming sites experienced fish 
mortality of unknown character. Autopsy findings of the fish point out ascites, yellowish 
liver, swollen spleen and petechiae in the perivisceral fatty tissue 36.Tests performed showed 
that the most common findings was pale heart due to severe epi- , endo- and myocarditis 33,36. 
The infested fish showed severe inflammation of the red skeletal muscle. Based on the gross 
and histopathological findings the disease was called heart and skeletal muscle inflammation 
(HSMI). The HSMI related lesions may histopathologicaly  resemble lesions found in fish 
with cardiomyopathy syndrome (CMS) 17 and pancreas disease (PD) 18,45. However, HSMI 
stands clearly out from these diseases. In HSMI the pancreas is not affected, and the affected 
compact layer of the heart found in cases with HSMI is rarely observed in cases with CMS 33. 
To investigate the cause and pathogenesis of HSMI, an experimental study was performed in 
2004. The study proved through cohabitation and by injection that the disease is 
transmissible34. Furthermore, an experimental transmission study 35 indicated that the casual 
agent is a virus. TEM studies of the disease have observed virus-like particles 77. Recent 
studies have found a new reovirus, with the suggested name Piscine reovirus (PRV), to be 
associated with HSMI. This virus is overrepresented in fish with HSMI and is also found to 
be associated with HSMI lesions  59. The diagnostic criteria for HSMI are based on 
histological examinations. 
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Cardiomyopathy syndrome (CMS) 
 
Cardiomyopathy syndrome (CMS) is a cardiac disease in farmed salmon. It was first 
discovered in Norway in the mid-1980s  1,17. Later on the disease has been detected in the 
Faroe Islands, Scottland and Canada 8,9,63. Generally farmed Atlantic salmon in sea cages are 
affected, but the condition is also seen in wild salmon61. CMS appears 14 to 18 months after 
transfer to seawater 17, and affects large fish that are ready for slaughter. Pathological findings 
indicate that CMS is a chronic disease that develops over a long period of time. 
Histopathological changes are found in the spongious myocardium of the atrium and 
ventricle. Typical findings are inflammatory cell infiltration, and proliferation of the 
endocardium9,17,23. An experimental transmission study done by Bruno et al.,  2009 9 
demonstrated that CMS could be reproduced in naïve Atlantic salmon by injecting tissue from 
affected fish. Epidemiological studies have previously indicated that CMS has an infectious 
causative agent 10,23. Recent publications support this statement. A novel piscine totivirus, 
named Piscine myocarditis virus (PMCV), is shown to be associated with the development of 
the disease 42. The diagnostic criteria for CMS are based on histological examinations. 
 
 
Priloferative gill inflammation (PGI) 
 
To diagnose gill related fish diseases is often challenging. The organ is exposed to the 
environment, and therefore the factors causing irritation may be numerous. The fish gills have 
relative few cell types. Different ethiology may therefore be manifested with similar 
histological changes.  Several studies have suggested a multifactorial etiology for gills 
described with proliferative gill inflammation. Causative factors may also be multiple 
enforcing each other. Gill damage may be induced by chemical and mechanical irritants like 
algae and jellyfish, poor water quality, opportunistic pathogens and primary pathogens 
(bacteria, uni- or multicellular parasites and fungi, viruses or amoeba). Atlantic salmon 
paramyxovirus (ASPV) has been suggested to take part in the development of PGI 37,38, the 
same with salmon gill poxvirus (SGPV) 54. Epitheliocysts caused by bacteria is also a typical 
finding in fish with PGI 52. Ichthyobodo sp. parasites have been seen in fish with PGI-like 
lesions. Recent studies have indicated that D. lepeoptherii can be related to PGI 21,51,69. PGI is 
a condition that has been known to farmed Atlantic salmon in Norway since the mid-1980’s. 
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Included in the classification of gills suffering from proliferative gill inflammation are four 
features; inflammation, cell death, epithelial hyperplasia and circulatory disturbances 38. The 
diagnostic criteria for PGI are based on histological examinations.  
 
 
Aims for the study 
 
There are two main goals for the study. 
1. Main goal one is to examine official diagnosed material for the presence of the 
microsporidian parasite D. lepeophtherii using Real time RT-PCR.  
2. Main goal two is to look for a possible relationship between D. lepeophtherii and the 
official diagnosis PD, HSMI, CMS, PGI and autumn disease. 
   
Subgoal for the study is to establish the use of formalin fixed paraffin embedded material 
for use in nucleic acid based research.  
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Materials 
 
In this thesis, (comma) is used as decimal separator as used in Norwegian orthography. As 
part of routine inspections and in connection to disease outbreaks formalin fixed tissue 
material from fish in different cultivation locations is sent to NVI. The material is then 
paraffin embedded and examined for possible diagnosis by histopathological methods. All 
paraffin embedded material is thereafter stored. Information of all material submitted to the 
NVI is stored in the sample journal system. The sample information is therefore retrievable by 
database searches.  
 
 
Figure 5 - Formalin fixed paraffin embedded tissue material (A), single organ (renal tissue) blocks NVIB, (B) 
multiorgan blocks NVIH 
 
This study will be based on paraffin embedded material with officially set diagnosis, PD, 
CMS, HSMB and PGI. In addition material with “autumn disease” will also be used. The 
latter is as mentioned above, not an official diagnosis. The material was gathered from year 
2005, 2008 and 2009 at the Norwegian Veterinary Institute Bergen (NVIB) and 2009 from the 
Norwegian veterinary institute in Harstad (NVIH). The year 2005 was chosen to include PD 
material before the common use of an anti SAV vaccine. This is also before the autumn 
disease outbreaks in 2008. The year 2009 was chosen to get PD material from after the 
introduction of a PD vaccine and after the 2008 autumn disease outbreaks. To ensure that the 
fish had a systemic microsporidian infection renal tissue was chosen. As far as possible each 
diagnosis was represented by 4 individuals from 10 cases for each year. Low outcome 
samples were re-purified once. If the yield was still low the sample was discharged as low 
A  B 
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DISEASE YEAR CASES INDIVIDUALS
PD (VIB) 2005 10 40
PD (VIB) 2008 10 40
PD (VIB) 2009 10 40
PD (VIH) 2009 2 30
HSMI (VIB) 2005 9 35
HSMI (VIB) 2008 8 31
HSMI (VIB) 2009 10 40
HSMI (VIH) 2009 11 42
PGI (VIB) 2005 9 24
PGI (VIB) 2008 7 27
PGI (VIB) 2009 8 27
PGI (VIH) 2009 6 15
CMS (VIB) 2005 9 27
CMS (VIB) 2008 3 9
CMS (VIB) 2009 6 16
CMS (VIH) 2009 10 27
"AUTUMN DISEASE" 2008 7 28
TOTAL NUMBER 135 498
quality. Altogether total RNA was purified from 498 individuals representing 135 diagnostic 
cases (Table 1). From these were a total of 468 individuals from 133 cases examined with the 
use of real time RT-PCR (Table 2) 
 
PURIFIED MATERIAL, number of individual samples 
Table 1 - Cases and individual samples purified. NVIB and NVIH 2005, 2008 and 2009 
 
PCR MATERIAL, number of individual samples 
Table 2 - PCR material from cases and individual samples. NVIB and NVIH 2005, 2008 and 2009 
 
 
 
 
 
 
 
 
 
DISEASE YEAR CASES INDIVIDUALS
PD (VIB) 2005 10 38
PD (VIB) 2008 10 38
PD (VIB) 2009 9 36
PD (VIH) 2009 1 16
HSMI (VIB) 2005 9 35
HSMI (VIB) 2008 8 30
HSMI (VIB) 2009 10 38
HSMI (VIH) 2009 11 42
PGI (VIB) 2005 9 23
PGI (VIB) 2008 7 27
PGI (VIB) 2009 7 25
PGI (VIH) 2009 6 14
CMS (VIB) 2005 9 26
CMS (VIB) 2008 3 9
CMS (VIB) 2009 6 16
CMS (VIH) 2009 10 27
"AUTUMN DISEASE" 2008 7 28
TOTAL NUMBER 133 468
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Methods 
 
RNA purification 
 
The purification of total RNA from formalin fixed paraffin embedded tissue sections was 
performed by using a specially designed kit (RNeasy®FFPE) from QIAGEN®.   
 
The method is performed according to the Qiagen user manual from January 2006 and 
September 2010. Steps involving xylene treatment were performed in a ventilation hood.  
By isolating RNA longer than 70 nucleotides, the kit provides restoration of usable RNA 
fragments suitable for real time RT- PCR. Due to embedding conditions and fixation, nucleic 
acids in paraffin embedded material, may be strong fragmented and chemically modified by 
formaldehyde. This kit is optimized to reverse the impact of formaldehyde without additional 
RNA degeneration. RNeasy FFPE also selectively removes double-stranded DNA from the 
material. Total RNA is purified from the sections due to specially optimized lysis conditions.  
 
General principles for the purification are as follows: Tissue sections that are freshly sliced 
are deparaffinized with xylene. The sections are thereafter washed with 100 % ethanol to 
remove the xylene. Further the samples are incubated with buffer PKD and proteinase K (both 
part of the RNeasy FFPE kit), an optimized lysis buffer that release RNA from the sections. 
Next the samples are incubated in higher temperatures for 2×15 minutes, first at 56ºC, and 
then at 80ºC. The higher temperatures reverse formalin cross linking of the nucleic acids, 
improving the RNA yield and sample quality. The samples were DNase treated (buffer and 
DNase part of the RNeasy FFPE kit). This handling is optimized to remove all genomic DNA, 
also including some small DNA fragments which often are present in FFPE samples after 
formalin fixation and long storage periods.  The samples are then mixed with Buffer RBC 
(part of the RNeasy FFPE kit) and ethanol. The ethanol is added because it supplies an 
appropriate binding condition for RNA to the matrix in specialized RNeasy Mini Elute spin 
columns. RNA bound to the column matrix was then washed with buffer RPE (part of the 
RNeasy FFPE kit) to remove non RNA material. The columns were centrifuged and allowed 
to dry for 5 minutes to remove all RPE buffer. It is important that the columns are dry, 
because residual ethanol may interfere with downstream reactions. The last step of the 
procedure is to elute the RNA with 30 µl RNase-free water that is placed directly on the spin 
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column membrane. After centrifugation on full speed for 1 minute the total RNA is collected 
in the bottom of the centrifugation tube. Pureness and concentration of the eluted RNA was 
determined with a Nanodrop 2000 spectrophometer. The spectrophometer measures RNA 
nucleic acid concentration (NAC) by measuring 260 nm absorbance (A260), concentrations 
and sample purity (260/280 nm ratio). RNA samples were stored at -80ºC until they are 
analyzed by real time RT-PCR.   
 
 
Real time PCR 
                                 
Polymerase chain reaction (PCR) allows for specific detection of minor amounts of a target 
DNA sequence by amplification of the sequence. Specificity of the reaction is ensured 
through the use of double thread dependent DNA polymerase and specific primers. Pre 
amplification reverse transcription from RNA to DNA with the use of reverse transcriptase 
makes it possible to also detect RNA sequences (reverse transcriptase PCR or RT-PCR). The 
process is well known and I will therefore not describe the amplification cycle in detail here. 
Real time PCR is a further development of the PCR technique. In real time PCR a probe with 
a fluorescing reporter and a quencher inhibiting the reporter will anneal to the targeted 
sequence between the primers. The Quencher is more electronegative than the reporter and 
will inhibit excitation of reporter electrons. The DNA polymerase used for the amplification 
has an exonuclease activity and will therefore fragmentize the probe separating the reporter 
and the quencher. This allows for excitation of the reporter and thereby a fluorescing signal. 
Each successful amplification will yield a fluorescence signal that will be detected by the real 
time PCR machine. This makes it possible to detect the outcome of each amplification cycle 
and not just the end product as in conventional PCR. Therefore the name real time PCR. This 
makes real time PCR useful for quantitative detection. Results from real time PCR analyzes 
are given as cycle of threshold values (Ct). This is the cycle when the machine starts to detect 
linear amplification results i.e. product doubling per cycle. 
 
Real time PCR was performed using OneStep RT-PCR kit from QIAGEN®. The real time 
RT-PCR amplification was performed on a Stratagene Mx 3005P QPCR System. Sequence 
for primers and probe specific for D. lepeophtherii (NUC), was as described by Nylund et al., 
2010 56. Primer probe concentrations for the assay were 600 nM for each primer and 175 nM 
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for the probe. Quality of the purified RNA material was assured  by the use of  the house-
keeping gene elongation factor 1 alpha (EF1A) 58. Primer probe concentrations for this essay 
were 900 nM for each primer and 200 nM for the probe. Template amount used was 
calculated based on RNA concentration outcome from the purification. The template quantity 
vitiated from 1 µl to 12, 5 µl (see appendix 1). The OneStep RT-PCR reaction mastermix was 
prepared with 4 µl RT-PCR buffer, 0.3 µl ROX, 0.8 µl dNTP, 0,2 µl NUC F, 0,2 µl NUC R, 
0,2 µl NUC probe (MGB), 1 µl MgCl2, 0,1 µl RNaseOut and 0,8 µl RT-PCR enzyme mix for 
each PCR well with a total mastermix of 7,6 µl. Volume was adjusted by adding water to a 
total of 20 µl reaction volume per sample. A sample previously diagnosed as autumn disease 
was found to have a high amount of D. lepeophtherii. RNA from this sample was diluted to 
give a Ct-value of 21 and used as a positive control in all assays throughout the study. A non 
template control (NTC) was also used in all assays. This was to investigate any possible 
contaminations. The real time RT-PCR analyses were performed by a Stratagene Mx 3005P 
QPCR System in these terms: Reverse transcription:  30 min at 50ºC. Initial PCR activation 
step: 15 min at 95ºC and 45 cycles of: denaturation; 30 sec at 94ºC, annealing; 45 sec at 55ºC 
and extension; 45 sec at 72ºC. In samples that were found to be negative, Ct-value was set to 
be 45 for easier evaluation for the results. As mentioned above elongating factor 1a (EF1A) 
was also amplied for each sample. This is a housekeeping gene used as endogen reference in 
salmon samples. Stable successful amplification of EF1A ensures both the quality of the 
purified RNA and the RT-PCR reaction. The analysis controls that the purification and PCR 
reaction have been successful. The quantity of the housekeeping gene determines the sample 
quality. High EF1A Ct-value indicates low template quality as long as the amount template 
added to the reaction is stable. These samples should be rejected. In cases where the EF1A Ct-
value diverged by more than 3 from the mode Ct-value of the total amplified group, the 
sample was rejected.  
 
A cut off value was estimated by making a two fold dilution serial of the positive control with 
three parallels. A real time RT-PCR analysis was performed for the detection of D. 
lepeophtherii. Cut off value was set as the cycle where one or more reactions were negative.  
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 Table 3 - Primers and probes used for real time RT-PCR 
Primer / probe Sequence Bp Position Reference 
Nuc- fwd 
Nuc- rev 
Nuc- probe 
5`-CGGACAGGGAGCATGGTATAG-`3  
5`-GGTCCAGGTTGGGTCTTGAG-`3  
5`-TTGGCGAAGAATGAAA-3`  
59 522-542 
580-561 
544-559 
Nylund et al., 
2010 
EF1AA-fwd 
EF1AA-rev 
EF1AA-probe 
5`-CCCCTCCAGGACGTTTACAAA-`3  
5`-CACACGGCCCACAGGTACA-3  
5`-ATCGGTGGTATTGGAAC-`3 
 
 
57 800-820 
839-857 
821-837 
Olsvik et al., 2005 
 
 
 
Calcofluor white stain 
 
This method detects organisms which contain chitin. Calcofluor (or bleach) binds to cellulose 
or chitin in the cell wall of fungi and microsporidia. A positive binding will fluoresce with 
green or blue colours when exposed toUV-light with the correct wavelength (optimal 
wavelength is 347 nm27). Morphology of fluorescing structures was used to determine the 
probability of the structure being a microsporidian spore.  
 
Kidney tissue from individuals with a D. lepeophtherii Ct-value similar to the mean value for 
each group (diagnosis, year and laboratory of origin) was chosen for calcofluor staining 
(Table 4). Only samples obtained from NVIB were used for calcofluor staining. Three µm 
tissue sections were placed on poly L-lysine coated slides. The thickness of the uncoloured 
sections was set to 3µm. The sections were deparaffinzed in xylene and rehydrated in ethanol 
(dilution series of 100, 96, 70, and 50 %, 3 minutes in each). The preparations were then 
encircled with a PAP-pen. After drying, the sections were added 1 drop of KOH (15%) and 1 
drop of calcofluor (FLUKA ®analytical 100 ml, cat. nr 18909). After 1 minute incubation, the 
samples were covered with a coverslip and microscoped with epifluorescense, 347 nm. The 
fluorescence microscopy was performed using a Nikon TE2000 microscope. 
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Table 4- Samples selected for the calcofluor white stain method.  
PD HSMI CMS PGI  AUTUMN 
DISEASE 
Samples Ct-
values 
Samples Ct-
values 
Samples Ct-
values 
Samples Ct-
values 
Samples Ct-
values 
F11/08-7 
 
33,45 
 
F417/08 
F474/08 
F200/09 
F150/09 
26,81 
26,82 
37,55 
37,69 
F24/08 32,98 F343/08 
F449/09 
F61/09 
21,57 
24,48 
28,68 
F419/08 
F379/08 
15,79 
22,87 
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Results 
 
Purification of paraffin embedded material 
 
Outcome of the RNA purification varied from 0 to 1000 ng/µl. Samples with low RNA yield 
showed correspondingly poor 260/280-ratio, and were disqualified from further use in the 
project. Submitted cassettes from each case had dissimilar amount of kidney tissue, and this 
was taken into account. If the tissue sample was too small, the number of cut sections was 
increased to get a sufficient amount of tissue.  
 
The purified materials submitted from the NVIH were multiorgan cassettes. Empirical 
observation from the tissue material was that the amount of sliced section could be different 
compared to the sections from the NVIB. Still, the results proved to function and there were 
no found differences on the purified samples and RNA concentrations from the two institutes.  
 
Real time RT-PCR results 
 
The results from the realtime RT-PCR analysis for the detection of D. lepeophtherii are given 
as average cycle-threshold value (Ct-value) ± standard deviation.  
Cut off value for the D. lepeophtherii assay was found to be Ct 38. Standard curve slope for 
the essay was -3,11. Efficiency E was 1,1. 
The results from the housekeeping gene give an indication of the quality of the purified RNA 
and are analyzed at the same time as the PCR for detecting D. lepeophtherii. As indicated in 
Figure 6 most EF1A Ct-values from each group clustered together. This indicated that the 
RNA in the material was intact and comparable. There was now difference in sample quality 
in between the different year groups.    
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Figure 6 - Results of real time RT-PCR Ct-values for HSMI 2009 NVIB.  (A) Amplification plots with primer probe 
specific for housekeeping gene (EF1A). (B) Amplification plots with primer probe specific for D. lepeophtherii. 
Diverging EF1A curves represent samples which are rejected (*), positive control (P).  
 
 
Pancreas disease 
 
Desmozoon lepeophtherii Ct- values for 2005, 2008 and 2009 PD samples (NVIB). 
 
Average real time RT-PCR results for PD cases at NVIB for 2005 were 41,3±5,2, for 2008 
36,0 ± 7,1 and for 2009 38,7 ± 5,8 (all values given as mean Ct-value ± standard deviation) 
(Fig. 7). Thirty-eight samples were originally analyzed for the detection of the parasite in 
cases with pancreas disease in 2005. Results from the amplification plots of housekeeping 
gene eliminated 7 samples that could not be taken into consideration due to low quality. Five 
of 10 diagnostic cases distributed from March to December were detected positive for D. 
lepeophtherii. Out of 31 individuals examined, 12 fish proved positive for D. lepeophtherii. 
From the year 2008, all samples analyzed had sufficient RNA quality. Nine out of 10 
diagnostic cases had positive individuals and 27 out of 38 individuals were positive for D. 
lepeophtherii.  Also all the analyzed material from individuals with the diagnosed pancreas 
disease in 2009 could be used. Eight out of 9 diagnostic cases had individuals positive for D. 
lepeophtherii and 23 out of 36 individuals tested positive for D. lepeophtherii. Numbers are 
shown in Table 4. 
B 
P 
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Figure 7- Real time RT-PCR results for D. Lepeophtherii specific analysis of PD diagnosed material from NVIB  
year 2005, 2008 and 2009. Results shown as Ct-values 
 
 
 
 
 
 
Table 4 - Displays an overview of PD diagnosed cases and samples from the Veterinary Institute Bergen (NVIB) 
investigated for D. lepeophtherii.. 
Year Total cases Individual 
samples 
Samples rejected 
due to low quality 
Positive samples 
2005 10 38 7 12 
2008 10 38 0 27 
2009 9 36 0 23 
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Heart and skeletal muscle inflammation 
 
D. lepeophtherii Ct- values for 2005, 2008 and 2009 HSMI samples (NVIB). 
 
Average real time RT-PCR result for HSMI Bergen 2005 was 37,4 ± 6,2, for 2008 27,2 ± 6,9 
and for 2009 38,4 ± 7,1 (all values  given as mean Ct-value ± standard deviation) (Fig. 8). A 
total of 35 individual samples from 9 cases diagnosed with heart and skeletal muscle 
inflammation (HSMI) were examined for the presence of the microsporidian parasite in 2005. 
All cases had one or more fish that showed positive Ct-values. Twenty-five out of 35 
individual samples were found positive for D. lepeophtherii. From 2008 30 samples were 
examined from 8 cases. Thirty out of 30 samples were found positive for D. lepeophtherii. 
From the year 2009, a total of 38 samples were examined. Three of these samples were 
rejected due to low quality RNA. Nineteen out of 38 samples were found positive for D. 
lepeophtherii. Numbers are shown in Table 5. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8- Real time RT-PCR results for D. Lepeophtherii specific analysis of HSMI diagnosed material from 
NVIB  year 2005, 2008 and 2009. Results shown as Ct-value 
 
Table 5 - Displays an overview of HSMI diagnosed cases and samples from the Norwegian Veterinary Institute 
Bergen (NVIB) investigated for D. lepeophtherii. 
Year Total cases Individual 
samples 
Rejected samples Positive samples 
2005 9 35 0 25 
2008 8 30 0 30 
2009 10 38 3 19 
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Cardiomyopathy syndrome  
 
D. lepeophtherii Ct- values for 2005, 2008 and 2009 CMS samples (NVIB) 
 
Average real time RT-PCR result for CMS Bergen 2005 was 36,7 ± 4,9, for 2008 34,4 ± 1,6 
and for 2009 33,0 ± 2,3 (all values given as mean Ct-value ± standard deviation) (Fig. 9). 
Generally there are fewer cases and individuals diagnosed with CMS in the southern part of 
Norway compared to mid and Northern Norway. In 2005 26 samples representing 9 cases 
were examined. Five samples were rejected due to low RNA quality. In 2008 3 cases with 9 
individual samples were examined. In 2009 6 diagnostic cases with 16 individuals were 
examined. Numbers are shown in Table 6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  9- Real time RT-PCR results for D. Lepeophtherii specific analysis of CMS diagnosed material from 
NVIB  year 2005, 2008 and 2009. Results shown as Ct-values 
 
 
Table 6 - Displays an overview of CMS diagnosed cases and samples from the Norwegian Veterinary Institute 
Bergen (NVIB) investigated for D. lepeophtherii. 
Year Total cases Individual 
samples 
Rejected samples Positive samples 
2005 9 26 5 17 
2008 3 9 0 9 
2009 6 16 0 16 
 30
Proliferative gill inflammation 
 
D. lepeophtherii Ct- values for 2005, 2008 and 2009 PGI samples (NVIB). 
 
Average real time RT-PCR result for PGI Bergen for 2005 was 30,0 ± 3,0, for 2008 23,0 ± 4,0 
and for 2009 29,3 ± 5,1 (all values are given as mean Ct-value ± standard deviation) (Fig.10). 
All samples studied were found positive for D. lepeophtherii. In 2005 23 individuals from 9 
cases were examined. In 2008 27 individuals distributed on 7 cases were examined. In 2009 
25 individuals distributed on 7 cases were examined. Two samples from 2005 and one sample 
from 2009 were rejected due to low RNA quality. Numbers are shown in Table 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 - Real time RT-PCR results for D. Lepeophtherii specific analysis of PGI diagnosed material from 
NVIB  year 2005, 2008 and 2009. Results shown as Ct-values 
 
 
 
 
 
Table 7 - Displays an overview of PGI diagnosed cases and samples from the Norwegian Veterinary Institute in 
Bergen (NVIB) investigated for D. lepeophtherii 
Year Total cases Individuals 
samples 
Rejected samples Positive samples 
2005 9 23 2 21 
2008 7 27 0 27 
2009 7 25 1 24 
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Autumn disease 
 
D. lepeophtherii Ct- values 2008 (NVIB) 
 
Average realtime result for autumn disease Bergen 2008 were 22,1 ± 5,0 (value is given as 
mean Ct-value ± standard deviation). Twenty-eight individuals distributed on 7 cases were 
examined (Fig. 11). All samples tested positive for D. lepeophtherii. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 - Real time RT-PCR results for D. Lepeophtherii specific real time PCR on autumn disease diagnosed 
material from NVIB year 2008. Results shown as Ct-values. 
 
 
 
 
Table 8 -Displays an overview of autumn disease diagnosed cases and samples from NVIB investigated for D. 
lepeophtherii. 
Year Total cases Individual 
samples 
Rejected samples Positive samples 
2008 7 28 0 28 
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Real time RT-PCR results from material obtained from NVIH 
 
Desmozoon lepeophtherii Ct- values from 2009 PD, HSMI, CMS and PGI samples NVIH 
 
Since there was only one outbreak of pancreas disease in Northern Norway in 2009, only this 
case was examined. Five out of 16 fish were positive for D. lepeophtherii in the real time RT-
PCR analysis. Average real time result for PD Harstad 2009 was 43,4 ± 2,61 (all values given 
as mean Ct-value ± standard deviation). Heart and skeletal muscle inflammation samples 
examined had 42 individuals distributed on 11 cases. Real time RT-PCR result for HSMI 
NVIH 2009 was 38,2 ± 5,2. Results from samples with CMS from NVIH were based on 10 
cases with 27 samples. One sample was rejected due to low quality RNA. Average real time 
result for CMS NVIH 2009 was 41,8 ± 4,9. From 6 cases with 16 fish alltogether suffering 
from PGI, only one individual proved to be positive for the parasite. The realtime results from 
PGI 2009 Harstad was 44, 9 ± 0,5. Ct-values shown in Fig. 12. Numbers of cases and 
individuals are shown in Table 9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 - Real time RT-PCR results for D. Lepeophtherii specific analysis of PD, HSMI, CMS and PGI 
diagnosed material from NVIH year 2009. Results shown as Ct-values.  
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Table 9 - Displays an overview of cases and samples from the Norwegian Veterinary Institute  Harstad (NVIH) 
investigated for D. lepeophtherii. 
Diagnosis Total cases Individual 
samples 
Rejected samples Positive samples 
PD 1 16 0 5 
HSMI 11 42 0 29 
CMS 10 27 1 9 
PGI 6 14 0 1 
 
 
 
Calcofluor white stain 
 
Results from the calcofluor white staining showed that D. lepeophtherii was present in 4 out 
of the 11 samples investigated (Fig. 13). Positive results indicating the microsporidium are 
shown as blue lighted spots in the pictures. The sample which represented PD 2008 (Fig. 13a) 
did not have any signs of the parasite. From the samples with HSMI 2008 (Fig.13b and c), 
one tested positive. HSMI samples from the year 2009 (Fig. 13d and e) were also negative. 
The CMS sample (Fig. 13f) was negative. The 2008 PGI sample tested negative (Fig. 13g) but 
the two 2009 PGI samples tested positive (Fig. 13h and i). Both 2008 autumn disease samples 
tested positive (Fig. 13j and k). Particularly the sample representing the individual with lowest 
Ct-value in the whole project (Fig. 13k) had a massive infiltration of the parasite in the kidney 
tissue.  
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Figure 13 - Calcofluor white stain material with individuals representing average Ct-value for each represented 
year and disease. PD 2008 (A), HSMI 2008, (B and C), HSMI 2009 (D and E), CMS 2008 (F), PGI 2008 (G), 
PGI 2009 (H and I), autumn disease (J and K). 
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Discussion 
 
In this work we have used the name Desmozoon lepeophtherii for the microsporidian 
suggested associated with the “autumn disease”. Choice of name is according to the official 
name policy of the Norwegian Veterinary Institute (NVI). 
 
Material and methods 
 
The primary goal for this study was to examine historical diagnostic material from the years 
2005, 2008 and 2009 for the presence of the microsporidian parasite D. lepeophtherii. Fish 
individuals that have been diagnosed with PD, HSMI, CMS and PGI were tested along with a 
“new” condition, called autumn disease from 2008 which were presumed associated with D. 
lepeophtherii. As a secondary goal we wanted to establish the use of blocks with formalin 
fixed paraffin embedded (FFPE) material in real time PCR based studies.  
 
From the Veterinary Institute in Bergen, all samples used in the study were single organ (renal 
tissue) paraffin blocks. The material from the Veterinary Institute in Harstad was multiorgan 
blocks.  Based on experience from the RNA purification of the FFPE materials, it was easier 
to perform optimal RNA purification from single organ material compared to the multiorgan 
material due to problems with estimating the correct amount of tissue to be used in the FFPE 
assay.  
 
The first samples purified were performed according to the user manual from 2006 
(RNeasy®FFPE handbook QIAGEN). In September 2010 QIAGEN did some changes to the 
kit, and these kits were used further in the project except once, when a delivery failure led to 
an old kit being delivered. When purifying with this “old” kit, the RNA yield was much lower 
than expected. This was probably because of storage at too high temperatures by the supplier. 
Formalin fixed and paraffin embedded tissues are known to have more fragmented RNA 
quality than RNA obtained directly from fresh tissues and tissues stored in RNAlater™. The 
RNeasy®FFPE kit used in this project is specialized to preserve and optimize recovering of 
fragmented RNA from the FFPE. Samples that pointed out to have low RNA yield, was 
purified twice to eliminate possible human errors. If they still had a low yield after the second 
purification, these samples were rejected.  RNA quality and yield are dependent on the quality 
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of the material. If the material is based on dead fish with cadaverous changes this will reduce 
the RNA quality. Insufficient fixation of the material will also lead to increased RNA 
detoriation 66. To take care of the organ quality, the tissue has to be handled correctly. 
According to the NVI’s user guide for sampling fish, the criteria for good fixation are 1:10 
ratio of tissue and formalin and 5 mm maximum thickness of the tissue 
(http://www.campec.net/brukerhandboka/Fisk/F001_fisk_ram.htm). Another issue that can be 
related to low RNA yield is errors regarding embedding of the organs. When preparing the 
paraffin embedded blocks, oxygen may come inside which then induce degeneration of the 
RNA. During the work with sectioning the FFPE blocks we experienced that some of the 
block had cavities and thereby exposing the tissue to oxygen. This would again, according to 
the RNeasy®FFPE user manual, lead to a decrease in RNA yield. All samples originally 
purified and those used in the project are listed in the appendix (Appendix 2). Of 498 samples 
used fore RNA purification 30 samples were rejected after purification. This indicates that 
most FFPE material has intact RNA. After purification, the total eluted RNA samples were 
stored at - 80ºC for further use for RT-PCR. 
 
PCR 
 
For the detection of the microsporidian parasite, real time RT-PCR was used with primers and 
probe specific for D. lepeophtherii. All handling of the purified RNA was minimized and 
during handling time the material was kept on ice. Purified RNA may have variable quality, 
and may also be unstable if stored over a period of time 66. As mentioned above the 
housekeeping gene was used in the study to check the quality of the purified RNA material. 
The real time RT-PCR results of the EF1A amplification indicated a good quality of the 
purified material. Of 449 samples analyzed with real time RT-PCR there was no difference in 
the average Ct-value of material from 2005, 2008 and 2009 (see Appendix 2).  This indicates 
that material older than 2005 also probably will be of sufficient quality for this type of 
analysis. Of 468 samples analyzed with real time RT-PCR 449 samples were rejected due to 
insufficient EF1A amplification.  This indicates that 96 % of the samples had good RNA 
quality.  
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Autumn disease 
 
The autumn disease was as mentioned above, first described in 2008. D. lepeohtherii was later 
suggested associated  with the condition 50. The results from the real time PCR amplifications 
show large amounts of D. lepeophtherii in kidney tissue from fish suffering from autumn 
disease. It is clearly that the fish individuals suffer from a systemic infection of the parasite. 
All autumn disease samples are positive for D. lepeohtherii with an average Ct-value of 22,1. 
The PCR results therefore seem to confirm that D. lepeophtherii is associated with autumn 
disease. The lowest Ct-value registered was 15,8, indicating that fish with autumn disease 
related clinical changes have large amount of spores. Comparison of real time RT-PCR results 
with histopathology based diagnostic answers showed that fish with clinical changes 
associated with autumn disease, seemed to have Ct-values below 25. Ct-values from 25-28 
represented an intermediate area with unclear clinical association. In fish with Ct-values from 
29 and up there were no clinical association.  
 
Proliferative gill inflammation 
 
All samples with the diagnosis PGI (years 2005, 2008 and 2009) at NVIB were found positive 
for D. lepeophtherii (average Ct-values were 30,0 ± 3,0 for 2005,  23,0 ± 4,0 for 2008 and 
29,3 ± 5,1 for 2009 respectively). The mean Ct-values found in the PGI material were o lower 
than what was observed in fish diagnosed with PD, HSMB and CMS. There is a significant 
increase in the amount of D. lepeophtherii in fish from 2008 compared to both 2005 and 2009 
(p<0,001). This is the same year as the autumn disease was reported to occur. Twenty out of 
27 investigated samples show Ct-values indicating high amounts of D. lepeophtherii in tissue 
material this year (Ct-values below 25). The mean Ct-value for 2008 is almost the same as 
was found for the autumn disease. This could indicate that D. lepeophtherii might be 
connected to the diagnosis of PGI in 2008. Ct-values from 2005 and 2009 are apparently the 
same with mean values around 30. Among these samples only a few individuals have Ct-
values which could indicate that the fish might have clinical problems with the parasitic 
infection. In the other individuals the parasite is present, but the Ct-values are regardless too 
high to indicate clinical illness. In the NVIH material from Northern Norway, 6 cases were 
studied. Only one individual had positive PCR results. However the Ct-value was so high, 
that we can only suggest the presence of the parasite. D. lepeophtherii is therefore not 
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associated with PGI in the material from Northern Norway. PGI is a condition with an unclear 
etiology and with probably several possible causal agents.  This is also reflected in the results 
here.  Based on these results, we can not exclude that there is a relationship between D. 
lepeophtherii and the diagnosis PGI. It looks like the parasite may be one of several factors 
that contribute to PGI. Higher D. lepeophtherii burden in PGI diagnosed salmon has also 
lately been confirmed by others 55 69. It is, however, unclear if the microsporidium is a 
primary causal agent or just a secondary invador of the diseased gills. 
. 
Pancreas disease 
 
The PCR results from cases with PD in Southern Norway (2005, 2008 and 2009 NVIB) show 
low presence of D. lepeophtherii (mean Ct-values for 2005 41,3 ± 5,2, for 2008 36,0 ± 7,1 
and for 2009 38,7 ± 5,8). In the NVIH material there was just one case from 2009. Mean Ct-
value for the samples in this case was 43,4 ± 2,6. None of the individuals had results 
indicating any clinical implication of the infection. Around 50% of the investigated 
individuals in the NVIB material were positive for the microsporidium. Around 30% of the 
individuals in the NVIH material were positive.  In the NVIB material there was tendency for 
higher amounts of the microsporidium in the 2008 material. This is corresponding to what 
was seen in the PGI material and support the impression of a higher total amount of D. 
lepeophtherii in farmed salmon in 2008. Altogether there is no support in the results for any 
association between PD and D. lepeophtherii as suggested by Nylund et al., 51. This is also 
supported by the fact that the numerical top for PD diagnosis is during the summer months 
while the top for the autumn disease cases is as suggested by the name, during the autumn 
months.  
 
Heart and skeletal muscle inflammation 
 
Mean PCR Ct-values for the HSMI material from NVIB were for 2005 37,4 ± 6,2, for 2008  
27,2 ± 6,9 and for 2009 38,4 ± 7,1. For 2005 and 2008 the values are approximately the same 
as found in the PD material. The mean Ct-values from both 2005 and 2009 are high and 
around the cut off value for the assay. Most of the samples from these years are positive for 
D. lepeophtherii, but in such low amounts that no clinical implication is expected. All samples 
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examined from year 2008 were positive for D. lepeophtherii. Several of the individuals have 
microsporidium burden in the same amount as have been seen associated with clinical 
changes. As seen from the official numbers of HSMI cases at NVIB (Fig. 14), 2008 was a 
year with few HSMI diagnosis. The PCR therefore seems to reflect the general higher D. 
lepeophtherii burden in farmed salmon this year, rather than a clinical association between D. 
lepeophtherii and HSMI. Most of the 2008 NVIB cases studied were also sampled during the 
autumn months resulting in a general higher D. lepeophtherii pressure. The HSMI (NVIH) 
material from Northern Norway showed mean Ct-results around the cut off value (38,2 ± 5,2). 
When one then takes into consideration that there are more cases with HSMI in Northern 
Norway than in Southern Norway (see Fig. 15) it appears to be no association between D. 
lepeophtherii and HSMI.  
 
 
 
 
 
 
Figure 14 - Number of cases diagnosed with HSMI at NVIB from 2007 to 2010. The figures show a drop in the 
number of cases in 2008. (Official numbers presented by NVIB at the 2011 user meeting) 
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Figure 15 - Map showing location of cases diagnosed with HSMI in 2010. 
(Map from the fish health report from the NVI) 7. 
 
Cardiomyopathy syndrome 
 
PCR results for CMS material from NVIB were for 2005 were 36,7 ± 4,9, for 2008 34,4 ± 1,6 
and for 2009 33,0 ± 2,3. There are few CMS cases each year at NVIB. The cases from the 3 
years studied in this project, covered just 46 individuals. The results are therefore suboptimal 
for mapping any potential connection between D. lepeophtherii and CMS. However, mean Ct-
values are so high that no clinical implication from the infection can be expected. The results 
from NVIH showed even lower values for the CMS material (41,8 ± 4,9) although one third 
of the samples were positive for D. lepeophtherii. Altogether these results indicate lack of 
association between D. lepeophtherii and CMS.  
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Calcofluor white stain 
 
The microsporidian sporewall contains chitin. The nonspecific chemofluorescent calcofluor 
binds to material such as cellulose and chitin. Calcofluor white stain was therefore used to 
detect D. lepeophtherii in the analyzed material. Since 1982 74, this method have been used to 
detect microsporidian spores in scientific connections. Calcofluor has an optimal excitation at 
wavelength 347 nm (DAPI). This type of stain is, as mentioned, nonspecific, and fungal 
spores and cellulose containing material present in the sample could also fluorescence. This 
could affect the final results. Still the salmon tissue investigated in this project was from 
individuals from the seawater phase, and the probability of any other fungal organism present 
in the kidney samples was minimal. Also small particles from paper could interfere with the 
calcofluor white stain and give false positives. The fluorescence organisms or particles in 
tissue samples had oval to round form. This indicates that microsporidian spores were 
detected. The samples chosen to be tested for the calcofluor white stain were selected based 
on the mean Ct-value the represented year. Results from PD 2008 was as expected negative in 
terms of the given average Ct-value (33,5). Two samples with HSMI 2008, and two from 
2009 were tested for the presence of the microsporidium to study the differences between 
these years. The two samples from 2009 were found negative, but one of the 2008 samples 
was positive and the other negative. From the mean Ct-value this year, the result was expected 
to be negative but one sample came up positive (Fig. 13b). The sample representing CMS 
2008 was negative with no signs of the parasite. This was expected because of the high 
average Ct-value proven from the PCR amplification. From the picture (Fig. 13f), the 
fluorescing structures observed are related to section artifacts. Regarding PGI, one sample 
from 2008, and two from 2009 (Fig.13g, h, i) were examined. It was expected that the sample 
from 2008 should be positive due to the low Ct-value, but this slice did not have any sign of 
the parasite (Fig. 13g). Also for 2009 only one of the PGI samples was found positive. As 
expected, both samples with autumn disease were found positive reflecting a high amount of 
spores in these tissues. The reason for the negative samples diverging from the PCR results is 
uncertain. During the experiment it was observed that some of the sections appeared to be 
insufficient deparaffinized and rehydrated, when KOH and calcofluor were applicated. This 
might have influenced the result and made some of the preparations appear falsely negative. 
The autumn disease material shows large amount of D. lepeophtherii in renal tissue from the 
affected individuals. This supports the observed association between the microsporidian and 
the autumn disease. Appearance of D. lepeophtherii in the PGI material could, however, not 
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be confirmed with this method. As mentioned above, this could be due to methodological 
problems.  
 
Summary 
 
The results show no association between D. lepeophtherii and the diagnoses PD, HSMI and 
CMS in the examined material. In general, the real time PCR results show a tendency for 
more D. lepeophtherii material in NVIB derived PD, HSMI and PGI samples from 2008 
compared to 2005 and 2009. For the PGI material the results suggest a possible association. 
This association is especially pronounced in the NVIB material from 2008. For the autumn 
disease material and the PGI 2008 material the results show an association to D. 
lepeophtherii. It is however unclear if the D. lepeophtherii is a primary disease cause or a 
secondary effect of the disease. Comparison between the NVIB and NVIH material show a 
higher D. lepeophtherii burden in the material from Southern Norway. In the NVIH material 
only minimal amounts of the parasite is detected. This may be due to the biology of the 
microsporidium. Microsporidian development appears to be temperature dependent. Other 
studies have concluded that microsporidian parasites (Loma salmonae 3,4,64, Enterocytozoon 
Salmonis 2 and Glugea Stephani 57) develop faster with higher temperatures. For optimal 
growth and germination of D. lepeophtherii, the temperature has to be about 15ºC. This is to 
reach optimal microsporidian replication conditions 53,55. Experience from the salmon louse 
laboratory at the Institute for Marine Research also supports this theory (Prof. Frank Nilsen 
personal comm.). There is also a lower louse burden in Northern Norway compared to the 
southern part of the country. These two factors can explain the lower presence of D. 
lepeophtherii in Northern Norway. 
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Conclusive remarks and future perspectives 
 
 
• The results from this study indicate lack of association between D. lepeophtherii 
and the diseases PD, HSMI and CMS. There is, however, a possible link between 
D. lepeophtherii and the diseases PGI and, autumn disease. This association is 
most pronounced for the diagnostic material from 2008.  
• The low D. lepeophtherii burden in the material from Northern Norway enhances 
the results showing lack of association between D. lepeophtherii and PD, HSMI 
and CMS. There is no connection between occurrence of disease and D. 
lepeophtherii burden. It also shows occurrence of PGI without a microsporidian 
infection.  
• The results show D. lepeophtherii infection to be common in farmed salmon in 
Southern Norway.  
• Calcofluor white stain can be used for the detection of microsporidian presence in 
tissue samples. 
• Use of formalin fixed paraffin embedded material is suitable for this kind of study. 
 
The results from this study open for future studies on archived formalin fixed paraffin 
embedded material. 
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Appendix 
 
Appendix 1 - Real-time RT-PCR set up 
 
Estimate of template amount 
 
RNA concentration: 
• < 75ng/µl:  12,5µl template added 
• 75-100ng/µl:  10µl template added 
• 100-200ng/µl:  5µl template added 
• 200-400ng/ul:  2,5µl template added  
• > 400ng/µl:  calculate amount and add 750ng 
 
 
 
Table 10 - Mastermix NUC: (buffer, dNTP and enzyme mix from OneStep kit QIAGEN) 
 
Reagent Starting concentration Final concentration 1-reaction 
RNasefree water - - (12,5.RNA)
RT-PCR buffer 5× 1× 4 
ROX reference dye 1 mM 30nM 0,3 
dNTP 10mM(each) 400µM (each) 0,8 
F 60µM 0,6µM 0,2 
R 60µM 0,6µM 0,2 
MGB 17,5µM 0,17µM 0,2 
MgCl2 25mM 1,25mM 1 
RNaseOut 40U/µl 4U 0,1 
RT-PCR enzyme mix - - 0,8 
Total   7,6 
 
   
Table 11- Mastermix EF1A: (buffer, dNTP and enzyme mix from OneStep kit QIAGEN) 
 
Reagent Starting concentration Final concentration 1-reaction 
RNasefree water - - (12,5.RNA)
RT-PCR buffer 5× 1× 4 
ROX reference dye 1 mM 30nM 0,3 
dNTP 10mM(each) 400µM (each) 0,8 
F 90µM 0,9µM 0,2 
R 90µM 0,9µM 0,2 
MGB 20µM 0,2µM 0,2 
MgCl2 25mM 1,25mM 1 
RNaseOut 40U/µl 4U 0,1 
RT-PCR enzyme mix - - 0,8 
Total   7,6 
 
Table 12 - RT-PCR Thermal Cycler performed in Stratagene Mx 3005P QPCR System 
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Temperature Time 
50°C 30 min 
95°C 15 min 
94°C 30 sec 
55°C 45 sec 
 72°C 45 sec 
}
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Appendix 2 - Fish data and PCR results 
 
 
 
Table 13 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). PD NVIB 2005. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
March F75/05 Kidney 226,4 2,03 Neg. 26,41 
March F75/05 Kidney 301,8 2,1 Neg. 24,25 
March F75/05 Kidney 366,1 1,92 Neg. 27,09 
March F75/05 Kidney 131,4 1,92 Neg. 29,55 
April F98/05 Kidney 165,7 2,07 Neg. 23,75 
April F98/05 Kidney 132,1 2,03 Neg. 23,17 
April F98/05 Kidney 362,7 2,07 Neg. 22,19 
April F98/05 Kidney 117,4 1,96 Neg. 26,88 
April F117/05 Kidney 1274,6 2,03 Neg. 23,28 
April F117/05 Kidney 502,1 2,04 Neg. 25,40 
April F117/05 Kidney 213,8 2,07 Neg. 25,70 
April F117/05 Kidney 301,6 2,06 Neg. 25,44 
April F122/05 Kidney 441,4 2,00 Neg. 24,34 
April F122/05 Kidney 124,4 2,05 Neg. 25,80 
April F122/05 Kidney 52,4 2,00 Neg. 27,56 
April F122/05 Kidney 640,7 2,07 Neg. 22,71 
July F228/05 Kidney 96,7 2,03 35,10 25,57 
July F228/05 Kidney 76,4 2,00 32,37 25,59 
July F228/05 Kidney 188,4 2,05 29,46 25,84 
July F228/05 Kidney 198,1 2,00 32,98 32,88 
August F240/05 Kidney 46,4 2,16 Neg. 25,27 
August F240/05 Kidney 339,9 1,99 Neg. 24,15 
August F240/05 Kidney 386,2 2,06 Neg. 23,00 
August F240/05 Kidney 516,3 2,00 Neg. 22,48 
September F287/05 Kidney 424,3 1,99 Neg. 28,37 
September F287/05 Kidney 518,8 2,01 43,19 22,88 
September F287/05 Kidney 856,7 2,03 Neg. 22,90 
September F295/05 Kidney 374,2 2,02 34,41 23,19 
September F295/05 Kidney 1037 1,99 34,22 23,32 
September F295/05 Kidney 336,2 2,03 Neg. 22,01 
October F312/05 Kidney 163,2 2,00 34,97 23,27 
October F312/05 Kidney 221,3 2,06 36,22 23,78 
October F312/05 Kidney 173,9 2,06 39,20 23,73 
October F312/05 Kidney 318,3 2,06 35,44 21,95 
December F375/05 Kidney 142,5 2,04 36,29 22,63 
December F375/05 Kidney 245,1 2,04 Neg. 25,97 
December F375/05 Kidney 245,5 2,07 Neg. 23,99 
December F375/05 Kidney 193,2 1,93 33,14 24,48 
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Table 14 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). PD 2008 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
January F11/08 Kidney 71,2 2,02 31,04 22,54 
January F11/08 Kidney 204,0 2,02 31,60 20,98 
January F11/08 Kidney 170,4 2,04 33,45 21,91 
January F11/08 Kidney 234,0 1,99 34,47 22,19 
January F21/08 Kidney 532,6 2,02 Neg. 20,62 
January F21/08 Kidney 237,5 2,02 Neg. 21,76 
January F21/08 Kidney 549,8 2,04 Neg. 21,18 
January F21/08 Kidney 348,2 1,99 32,75 21,36 
January F25/08 Kidney 266,6 2,06 Neg. 23,82 
January F25/08 Kidney 151,7 2,03 40,88 22,99 
January F25/08 Kidney 241,2 1,96 Neg. 24,31 
January F25/08 Kidney 337,8 2,03 41,79 23,20 
April F95/08 Kidney 132,0 2,05 Neg. 21,59 
April F95/08 Kidney 214,9 2,04 34,69 22,72 
April F95/08 Kidney 224,2 2,04 Neg. 22,40 
May F188/08 Kidney 391,6 2,02 Neg. 22,70 
May F188/08 Kidney 188,1 2,03 Neg. 21,96 
May F188/08 Kidney 535,7 2,03 Neg. 22,89 
May F188/08 Kidney 451,3 2,04 Neg. 23,25 
June F195/08 Kidney 299,0 2,07 29,93 22,01 
June F195/08 Kidney 210,0 2,08 36,38 21,31 
June F195/08 Kidney 135,7 2,08 30,89 21,80 
June F195/08 Kidney 157,9 2,08 24,31 20,99 
June F216/08 Kidney 152,8 1,98 29,40 24,34 
June F216/08 Kidney 96,6 1,99 37,78 23,60 
June F216/08 Kidney 289,5 2,02 41,15 24,09 
June F216/08 Kidney 264,7 2,00 27,88 23,99 
August F332/08 Kidney 65,5 2,00 32,10 24,24 
August F332/08 Kidney 111,3 1,84 34,01 24,73 
August F332/08 Kidney 108,3 1,92 29,63 23,19 
August F334/08 Kidney 48,6 2,09 27,01 26,09 
August F334/08 Kidney 51,1 2,09 27,17 24,79 
August F334/08 Kidney 40,6 2,11 34,45 25,72 
August F334/08 Kidney 61,0 1,81 29,56 25,74 
September F372/08 Kidney 166,1 2,00 35,41 23,04 
September F372/08 Kidney 98,4 2,00 26,14 21,93 
September F372/08 Kidney 113,2 2,02 24,22 22,42 
September F372/08 Kidney 52,1 2,09 33,87 22,88 
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Table 15 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). PD 2009 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
April F127/09 Kidney 111,7 2,02 Neg. 22,77 
April F127/09 Kidney 221,2 2,02 Neg. 22,75 
April F127/09 Kidney 149,2 1,99 44,27 22,39 
April F127/09 Kidney 138,9 2,01 Neg. 22,91 
May F193/09 Kidney 145,9 1,98 33,02 23,33 
May F193/09 Kidney 210,7 2,02 38,38 22,77 
May F193/09 Kidney 77,9 1,97 36,62 23,62 
May F193/09 Kidney 108,4 2,02 Neg. 23,63 
June F211/09 Kidney 186,9 1,96 Neg. 23,53 
June F211/09 Kidney 153,3 2,01 Neg. 25,29 
June F211/09 Kidney 246,1 2,02 Neg. 24,38 
June F211/09 Kidney 27,1 1,90 Neg. 25,83 
July F267/09 Kidney 128,5 1,96 Neg. 25,71 
July F267/09 Kidney 114,6 1,97 Neg. 25,17 
July F267/09 Kidney 52,9 1,96 30,27 25,16 
July F267/09 Kidney 142,9 2,01 33,99 24,96 
July F279/09 Kidney 71,7 2,05 32,28 21,73 
July F279/09 Kidney 122,6 2,05 36,48 21,95 
July F279/09 Kidney 123,5 1,99 37,94 21,65 
July F279/09 Kidney 118,4 2,00 27,99 22,15 
July F286/09 Kidney 87,5 1,99 42,98 22,11 
July F286/09 Kidney 52,0 2,04 Neg. 23,20 
July F286/09 Kidney 54,1 1,85 Neg. 23,31 
July F286/09 Kidney 22,0 1,76 Neg. 22,66 
July F298/09 Kidney 151,1 1,91 32,49 26,75 
July F298/09 Kidney 73,3 1,86 37,39 27,00 
July F298/09 Kidney 52,3 1,93 35,12 25,98 
July F298/09 Kidney 66,6 1,85 34,13 27,26 
August F308/09 Kidney 76,2 1,85 31,16 22,67 
August F308/09 Kidney 54,2 1,95 37,74 22,72 
August F308/09 Kidney 49,8 1,94 30,30 22,9 
August F308/09 Kidney 91,5 1,91 31,71 22,28 
August F309/09 Kidney 34,1 2,05 31,08 23,91 
August F309/09 Kidney 105,8 1,94 41,22 23,21 
August F309/09 Kidney 76,0 2,01 39,00 22,13 
August F309/09 Kidney 29,4 1,95 34,28 23,73 
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Table 16 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). PD 2009 NVIH. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct- value 
November 12641,1,1 Multiorgan 2110,0 2,07 37,59 21,09 
November 12641,1,3 Multiorgan 258,3 2,07 39,89 21,64 
November 12641,1,4 Multiorgan 441,7 2,06 38,83 20,65 
November 12641,1,5 Multiorgan 389,3 2,06 Neg. 21,63 
November 12641,1,6 Multiorgan 218,6 2,08 Neg. 22,15 
November 12641,1,7 Multiorgan 588,7 2,10 Neg. 21,75 
November 12641,1,10 Multiorgan 385,1 2,07 Neg. 21,13 
November 12641,2,2 Multiorgan 425,8 2,00 Neg. 20,99 
November 12641,2,3 Multiorgan 601,6 2,00 Neg. 21,30 
November 12641,2,4 Multiorgan 1152,5 1,94 Neg. 19,68 
November 12641,2,5 Multiorgan 580,8 2,05 Neg. 21,76 
November 12641,2,6 Multiorgan 162,8 2,04 42,68 21,75 
November 12641,2,7 Multiorgan 446,6 1,96 41,09 22,14 
November 12641,2,8 Multiorgan 495,6 2,04 Neg. 21,82 
November 12641,2,9 Multiorgan 161,9 2,06 Neg. 21,94 
November 12641,2,11 Multiorgan 207,9 2,01 Neg. 21,01 
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Table 17 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). HSMI 2005 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC  
Ct- value 
EF1A 
Ct- value 
February F31/05 Kidney 696,2 2,01 34,16 21,28 
February F31/05 Kidney 1078,2 1,99 29,65 21,63 
February F31/05 Kidney 456,0 2,02 29,87 21,35 
February F31/05 Kidney 663,7 2,00 24,06 22,43 
April F128/05 Kidney 135,8 1,96 34,68 25,52 
April F128/05 Kidney 147,5 1,89 39,96 25,47 
April F128/05 Kidney 189,7 2,00 Neg. 25,42 
April F128/05 Kidney 321,2 1,99 Neg. 24,23 
April F131/05 Kidney 290,2 2,03 Neg. 23,57 
April F131/05 Kidney 497,1 1,87 43,53 23,10 
April F131/05 Kidney 267,6 2,06 Neg. 23,81 
April F131/05 Kidney 679,6 1,97 37,60 23,43 
May F135/05 Kidney 1059,4 2,01 Neg. 21,29 
May F135/05 Kidney 1021,0 2,00 33,83 23,14 
May F135/05 Kidney 631,6 1,99 34,72 23,04 
May F135/05 Kidney 756,7 1,98 34,36 22,91 
June F173/05 Kidney 119,7 1,97 Neg. 23,11 
June F173/05 Kidney 159,3 2,03 42,08 24,36 
June F173/05 Kidney 159,4 2,04 36,48 24,71 
June F173/05 Kidney 107,2 2,00 Neg. 23,07 
June F184/05 Kidney 218,9 1,99 29,07 25,48 
June F184/05 Kidney 303,8 1,97 29,47 23,85 
June F184/05 Kidney 357,5 1,97 32,98 24,69 
June F184/05 Kidney 549,4 1,92 Neg. 24,04 
June F188/05 Kidney 302,1 2,04 Neg. 24,27 
June F188/05 Kidney 434,6 2,02 40,35 24,39 
June F188/05 Kidney 368,9 2,04 38,46 24,68 
June F188/05 Kidney 280,7 2,05 36,10 24,42 
June F198/05 Kidney 273,4 1,96 30,55 23,32 
June F198/05 Kidney 260,2 2,03 Neg. 24,15 
June F198/05 Kidney 342,0 2,04 31,35 23,16 
October F319/05 Kidney 684,8 1,97 34,19 23,49 
October F319/05 Kidney 735,1 1,95 33,67 23,48 
October F319/05 Kidney 564,1 1,94 32,36 22,61 
October F319/05 Kidney 516,6 1,96 34,56 22,35 
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Table 18 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). HSMI 2008 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct- value 
EF1A 
Ct- value 
January F23/08 Kidney 607,5 1,92 38,13 25,65 
January F23/08 Kidney 449,8 2,02 33,19 23,10 
January F23/08 Kidney 389,6 2,04 30,09 23,97 
January F23/08 Kidney 65,0 2,01 30,45 21,69 
March F83/08 Kidney 61,8 1,94 16,65 22,89 
March F83/08 Kidney 173,5 1,89 44,43 26,47 
March F83/08 Kidney 138,6 1,91 33,72 24,73 
March F83/08 Kidney 233,3 1,94 30,69 25,77 
June F259/08 Kidney 161,2 1,96 32,86 23,27 
June F259/08 Kidney 151,2 1,92 35,04 24,67 
June F259/08 Kidney 70,9 1,80 32,50 25,44 
September F340/08 Kidney 142,0 1,97 29,97 28,02 
September F340/08 Kidney 108,7 1,95 30,28 26,94 
September F340/08 Kidney 161,7 1,92 18,65 25,54 
September F373/08 Kidney 229,9 2,01 24,27 24,74 
September F373/08 Kidney 122,1 2,03 25,65 26,37 
September F373/08 Kidney 103,3 2,06 21,93 27,46 
September F373/08 Kidney 105,4 1,98 19,24 25,96 
September F375/08 Kidney 218,8 2,00 18,06 23,95 
September F375/08 Kidney 170,4 2,00 20,99 23,02 
September F375/08 Kidney 168,2 2,00 18,15 23,58 
September F375/08 Kidney 381,7 2,01 18,07 21,67 
October F417/08 Kidney 219,2 1,99 24,82 29,07 
October F417/08 Kidney 154,9 2,03 23,10 23,06 
October F417/08 Kidney 201,3 2,01 26,81 22,83 
October F417/08 Kidney 148,0 2,02 18,39 23,35 
December F474/08 Kidney 224,3 2,06 26,82 23,68 
December F474/08 Kidney 173,6 2,06 28,32 23,99 
December F474/08 Kidney 207,2 2,06 31,94 27,53 
December F474/08 Kidney 71,1 1,69 31,94 23,30 
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Table 19 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). HSMI 2009 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
February F40/09 Kidney 170,6 1,93 28,30 21,57 
February F40/09 Kidney 200,7 2,02 24,26 21,73 
February F40/09 Kidney 160,9 2,04 31,78 22,72 
February F40/09 Kidney 144,2 2,09 27,36 23,05 
March F110/09 Kidney 49,4 2,08 31,82 25,19 
March F110/09 Kidney 67,1 2,08 27,77 23,52 
March F110/09 Kidney 66,2 2,08 30,46 23,49 
March F110/09 Kidney 54,9 2,07 31,68 23,23 
April F139/09 Kidney 131,5 2,03 34,61 23,12 
April F139/09 Kidney 110,4 2,03 Neg. 23,98 
April F139/09 Kidney 55,9 1,83 Neg. 25,39 
April F139/09 Kidney 154,7 2,40 37,21 24,63 
April F150/09 Kidney 342,5 2,03 Neg. 21,10 
April F150/09 Kidney 284,7 2,04 40,42 21,66 
April F150/09 Kidney 445,8 2,02 Neg. 22,50 
April F150/09 Kidney 305,6 2,02 37,69 20,96 
May F160/09 Kidney 171,0 2,05 Neg. 21,92 
May F160/09 Kidney 85,5 2,04 Neg. 22,62 
May F160/09 Kidney 251,1 1,93 Neg. 39,68 
May F160/09 Kidney 258,0 2,02 Neg. 22,37 
May F164/09 Kidney 12,6 2,02 Neg. 27,73 
May F164/09 Kidney 65,1 1,95 Neg. 24,35 
May F164/09 Kidney 47,6 1,93 Neg. 24,66 
May F164/09 Kidney 50,3 1,83 36,20 25,40 
June F200/09 Kidney 37,9 2,03 Neg. 25,63 
June F200/09 Kidney 39,5 2,03 37,55 23,88 
June F200/09 Kidney 63,0 1,89 Neg. 25,06 
June F200/09 Kidney 59,4 1,94 Neg. 22,67 
June F203/09 Kidney 70,3 2,05 38,25 23,11 
June F203/09 Kidney 150,0 1,75 Neg. 23,87 
June F203/09 Kidney 48,5 1,94 Neg. 26,90 
June F203/09 Kidney 58,9 2,09 42,28 23,58 
June F245/09 Kidney 143,0 2,07 Neg. 23,17 
June F245/09 Kidney 181,2 1,88 Neg. 23,70 
June F245/09 Kidney 33,8 2,14 Neg. 24,31 
July F275/09 Kidney 43,7 2,13 33,15 24,58 
July F275/09 Kidney 37,7 2,10 29,05 24,92 
July F275/09 Kidney 42,0 2,05 27,66 25,37 
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Table 20 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). HSMI 2009 NVIH. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
June 9692,1 Multiorgan 46,1 1,99 33,68 24,69 
June 9692,2 Multiorgan 219,3 1,93 34,67 23,50 
June 9692,3 Multiorgan 124,8 1,96 34,36 24,84 
June 9692,4 Multiorgan 117,3 1,81 35,78 25,72 
September 13643,1 Multiorgan 120,4 2,01 31,10 23,82 
September 13645,1,1 Multiorgan 251,6 1,98 33,53 23,54 
September 13645,2,1 Multiorgan 282,6 2,01 35,32 22,42 
September 13649,1 Multiorgan 118,3 2,00 36,25 25,34 
September 13650,1 Multiorgan 269,9 1,99 Neg. 22,63 
September 14181,1,1,1 Multiorgan 123,0 2,00 Neg. 23,59 
September 14181,1,2,1 Multiorgan 59,7 2,03 36,24 24,22 
September 14182,1 Multiorgan 342,1 2,01 37,20 21,74 
September 14193,1,1,1 Multiorgan 118,4 1,74 39,65 22,77 
September 14183,1,2,1 Multiorgan 256,1 2,01 Neg. 22,20 
September 14962,1,2,1 Multiorgan 287,1 2,00 Neg. 21,53 
September 14962,1,3,1 Multiorgan 501,5 2,01 Neg. 20,91 
September 14962,1,4,1 Multiorgan 446,2 2,04 41,00 21,43 
September 15209,3,2,1 Multiorgan 338,1 2,03 Neg. 21,09 
September 15209,3,3,1 Multiorgan 151,1 2,07 37,86 21,51 
September 15209,3,4,1 Multiorgan 230,3 20,3 39,66 21,59 
September 15209,3,5,1 Multiorgan 120,8 2,11 32,56 21,26 
September 15209,3,6,1 Multiorgan 248,8 1,95 34,46 22,89 
September 15209,3,7,1 Multiorgan 130,0 2,10 Neg. 21,26 
September 15209,3,8,1 Multiorgan 218,0 2,06 Neg. 21,69 
September 15209,3,8,1 Multiorgan 190,6 2,03 Neg. 21,81 
October 16270,1,1,1 Multiorgan 100,7 1,92 38,68 24,24 
October 16270,1,2,1 Multiorgan 128,4 1,83 36,75 24,87 
October 16270,1,3,1 Multiorgan 72,6 1,91 34,82 24,88 
October 16270,1,4,1 Multiorgan 59,6 1,95 33,57 23,15 
October 16270,1,5,1 Multiorgan 15,3 1,91 34,82 27,01 
November 18528,1 Multiorgan 31,2 2,04 33,84 24,67 
November 18529,1,1,1 Multiorgan 6,1 2,02 36,28 28,69 
November 18529,1,2,1 Multiorgan 8,4 2,09 35,71 26,57 
November 18529,1,3,1 Multiorgan 37,5 2,02 34,15 24,57 
November 19382,1(1-2)1 Multiorgan 110,0 1,97 Neg. 22,33 
November 19382,1,3-5,1 Multiorgan 144,3 1,98 Neg. 22,78 
November 19558,1,1,1 Multiorgan 101,2 1,80 Neg. 23,37 
November 19558,1,2,1 Multiorgan 219,3 2,00 36,79 23,22 
November 19559,1,1,1 Multiorgan 150,0 1,99 28,92 24,29 
November 19559,1,2,1 Multiorgan 199,4 1,98 30,87 22,27 
December 2045,1(1-2)1 Multiorgan 127,9 2,00 Neg. 22,21 
December 2045,1(3-4)1 Multiorgan 423,5 2,02 29,59 21,90 
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Table 21 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). CMS 2005 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
January F18/05 Kidney 227,3 1,98 Neg. 27,75 
January F18/05 Kidney 554,9 1,98 40,31 24,83 
February F29/05 Kidney 29,7 2,04 33,16 23,83 
February F29/05 Kidney 261,3 2,04 32,58 26,24 
February F29/05 Kidney 330,3 2,04 33,69 27,04 
February F29/05 Kidney 202,6 2,01 33,54 26,56 
March F83/05 Kidney 179,5 2,14 31,89 24,98 
March F83/05 Kidney 442,8 2,06 33,91 22,18 
March F83/05 Kidney 553,1 2,00 32,31 24,37 
June F192/05 Kidney 256,8 2,01 31,97 24,11 
June F192/05 Kidney 359,8 2,07 33,92 26,24 
June F192/05 Kidney 358,9 2,07 35,53 23,35 
June F192/05 Kidney 331,0 2,03 37,82 29,28 
September F293/05 Kidney 343,6 2,04 34,17 24,97 
September F293/05 Kidney 244,2 2,03 32,35 Neg. 
October F311/05 Kidney 380,2 2,02 38,77 24,81 
October F311/05 Kidney 670,0 2,02 33,00 26,58 
October F311/05 Kidney 215,6 1,91 Neg. 30,41 
October F313/05 Kidney 397,5 1,92 37,79 25,85 
October F313/05 Kidney 510,4 1,99 31,14 25,83 
October F327/05 Kidney 67,5 1,85 Neg. 29,51 
October F327/05 Kidney 62,3 2,77 34,58 26,65 
October F327/05 Kidney 437,8 2,00 Neg. 25,97 
October F327/05 Kidney 217,0 1,90 Neg. 28,31 
November F336/05 Kidney 258,1 1,95 36,23 27,66 
November F336/05 Kidney 351,2 2,04 40,68 26,27 
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Table 22 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). CMS 2008 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
January F24/08 Kidney 304,7 2,08 32,83 23,93 
January F24/08 Kidney 440,4 2,03 32,98 23,45 
February F70/08 Kidney 574,4 1,99 35,47 24,23 
February F70/08 Kidney 354,3 2,05 32,94 23,62 
February F70/08 Kidney 668,8 2,00 34,78 22,87 
March F75/08 Kidney 459,7 2,03 34,11 22,71 
March F75/08 Kidney 256,7 2,03 38,00 23,93 
March F75/08 Kidney 213,3 1,96 34,40 25,52 
March F75/08 Kidney 564,2 1,96 33,70 23,62 
 
 
 
 
 
 
 
 
Table 23 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). CMS 2009 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
February F54/09 Kidney 460,8 2,04 35,63 24,07 
February F54/09 Kidney 77,9 1,89 30,80 24,79 
March F112/09 Kidney 140,5 1,97 35,68 25,19 
March F112/09 Kidney 180,6 1,99 34,66 24,40 
March F112/09 Kidney 139,0 1,97 33,02 25,05 
March F112/09 Kidney 331,0 2,05 34,20 23,30 
March F141/09 Kidney 72,6 1,96 31,04 25,97 
July F285/09 Kidney 301,9 2,05 36,74 23,33 
July F285/09 Kidney 297,6 2,03 32,37 23,46 
July F285/09 Kidney 311,7 2,03 30,81 23,44 
July F285/09 Kidney 288,4 2,02 31,98 23,14 
September F329/09 Kidney 142,5 1,98 34,27 24,49 
September F329/09 Kidney 105,1 2,05 33,25 23,54 
September F329/09 Kidney 125,2 1,79 31,73 24,12 
December F514/09 Kidney 156,2 2,00 33,71 23,51 
December F514/09 Kidney 150,4 1,92 27,92 24,11 
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Table 24 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). CMS 2009 NVIH. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
January 1537,1,1,1 Multiorgan 83,0 2,00 32,76 23,11 
January 1537,1,2,1 Multiorgan 188,0 1,96 32,62 22,61 
January 1537,1,3,1 Multiorgan 350,9 1,97 41,07 22,10 
January 1537,1,4,1 Multiorgan 164,7 1,97 35,42 22,92 
January 1537,1,5,1 Multiorgan 167,3 1,97 39,00 22,70 
January 1579,1,1,1 Multiorgan 357,7 1,96 Neg. 21,84 
January 1579,1,2,1 Multiorgan 530,1 1,96 Neg. 21,01 
January 1579,1,3,1 Multiorgan 332,5 1,99 Neg. 23,29 
March 4611,1,1,1 Multiorgan 255,4 1,93 Neg. 22,83 
March 4611,1,2,1 Multiorgan 182,7 1,89 Neg. 22,71 
April 6566,1,1,1 Multiorgan 166,3 1,97 Neg. 22,27 
April 6566,1,2,1 Multiorgan 101,1 2,02 Neg. 22,80 
April 6566,1,3,1 Multiorgan 420,4 1,97 Neg. 22,39 
June 9685,1,1 Multiorgan 68,8 1,98 Neg. 24,41 
June 9685,2,1 Multiorgan 80,0 1,97 Neg. 24,26 
July 11214,1 Multiorgan 71,2 1,99 Neg. 22,31 
August 11847,1,1 Multiorgan 42,8 1,94 Neg. 26,82 
August 11847,2,1 Multiorgan 144,8 1,98 Neg. 22,82 
August 11847,3,1 Multiorgan 356,2 1,97 Neg. 21,49 
August 11847,4,1 Multiorgan 235,6 2,00 Neg. 21,90 
August 11847,5,1 Multiorgan 26,5 2,09 Neg. 22,72 
September 16985,1,1,1 Multiorgan 61,7 1,87 29,24 24,39 
September 16985,1,2,1 Multiorgan 56,8 1,86 38,22 24,29 
September 16985,1,3,1 Multiorgan 149,7 1,83 36,49 24,25 
September 16985,1,5,1 Multiorgan 111,7 1,82 Neg. 24,20 
October 17825,1 Multiorgan 44,1 1,88 Neg. 23,61 
November 18986,1 Multiorgan 70,6 2,01 38,11 23,06 
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Table 25 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). PGI 2005 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
January F22/05 Kidney 419,7 2,02 27,38 25,75 
January F22/05 Kidney 285,2 2,05 25,84 24,87 
January F22/05 Kidney 995,2 2,02 25,75 25,36 
April F299/05 Kidney 330,5 2,03 28,95 23,47 
June F195/05 Kidney 263,3 1,92 Neg. 28,97 
June F195/05 Kidney 429,2 1,97 35,63 25,13 
June F195/05 Kidney 454,8 1,99 30,88 24,45 
June F195/05 Kidney 408,6 1,97 34,84 24,66 
June F282/05 Kidney 343,1 2,01 25,88 23,55 
June F282/05 Kidney 165,1 1,96 27,98 24,40 
August F264/05 Kidney 336,7 2,21 28,53 24,75 
August F264/05 Kidney 128,8 1,94 28,48 25,26 
October F325/05 Kidney 451,6 2,00 27,95 24,26 
October F325/05 Kidney 320,8 2,02 29,51 24,02 
November F340/05 Kidney 728,7 1,96 33,88 22,98 
November F340/05 Kidney 602,9 1,99 27,85 23,49 
November F340/05 Kidney 450,9 1,98 31,19 21,47 
November F340/05 Kidney 506,9 1,97 31,83 23,82 
November F344/05 Kidney 491,6 1,97 28,04 22,62 
November F344/05 Kidney 463,3 2,03 32,51 23,20 
November F344/05 Kidney 108,8 1,95 31,58 25,43 
December F371/05 Kidney 672,2 1,97 28,52 23,70 
December F371/05 Kidney 610,0 1,99 34,18 25,04 
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Table 26 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). PGI 2008 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
January F12/08 Kidney 236,8 1,99 26,49 22,75 
January F12/08 Kidney 323,8 2,05 24,74 23,16 
January F12/08 Kidney 1091,4 2,04 23,37 21,13 
January F12/08 Kidney 356,6 2,06 26,33 22,57 
September F343/08 Kidney 274,4 1,94 19,99 22,42 
September F343/08 Kidney 300,7 2,02 18,74 22,89 
September F343/08 Kidney 178,6 1,97 21,57 22,91 
September F343/08 Kidney 204,3 2,02 23,91 24,98 
September F345/08 Kidney 139,5 1,93 30,69 24,64 
September F345/08 Kidney 107,0 1,95 29,91 24,68 
September F345/08 Kidney 137,8 1,94 21,94 23,67 
September F345/08 Kidney 232,4 1,91 32,19 25,22 
September F356/08 Kidney 377,1 2,00 16,92 22,68 
September F356/08 Kidney 96,8 1,98 18,90 22,87 
September F356/08 Kidney 321,2 1,90 24,27 22,96 
September F356/08 Kidney 84,6 1,97 23,06 23,29 
September F360/08 Kidney 144,3 2,01 23,71 22,54 
September F360/08 Kidney 410,8 2,03 20,06 22,22 
September F360/08 Kidney 164,7 1,91 20,02 23,31 
September F360/08 Kidney 79,0 2,03 25,30 22,66 
September F374/08 Kidney 238,3 1,98 27,82 24,11 
September F374/08 Kidney 108,2 1,94 23,15 24,55 
September F374/08 Kidney 146,7 1,92 21,77 23,73 
October F419/08 Kidney 332,2 2,06 18,83 21,51 
October F419/08 Kidney 480,5 1,98 19,24 22,51 
October F419/08 Kidney 525,5 1,98 18,15 21,99 
October F419/08 Kidney 420,8 2,05 18,64 21,28 
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Table 27 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). PGI 2009 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
Febryary F61/09 Kidney 352,5 2,06 37,02 22,42 
Febryary F61/09 Kidney 333,5 2,06 31,27 Neg. 
Febryary F61/09 Kidney 259,3 2,01 26,95 22,13 
Febryary F61/09 Kidney 287,0 2,03 28,68 21,68 
September F357/09 Kidney 84,2 1,68 23,40 22,01 
September F357/09 Kidney 445,7 1,93 32,86 21,54 
September F357/09 Kidney 388,8 1,99 27,44 22,18 
September F387/09 Kidney 93,2 2,00 33,73 23,89 
September F387/09 Kidney 45,1 1,86 39,52 23,63 
September F387/09 Kidney 158,7 1,98 20,08 23,26 
September F387/09 Kidney 95,4 1,87 23,19 23,87 
November F449/09 Kidney 512,8 1,98 30,36 23,96 
November F449/09 Kidney 320,8 1,98 24,48 23,72 
November F449/09 Kidney 285,5 2,04 29,78 22,36 
November F449/09 Kidney 347,2 2,04 21,60 21,54 
November F453/09 Kidney 283,2 2,02 34,64 21,84 
November F453/09 Kidney 76,2 1,95 30,96 22,75 
November F453/09 Kidney 302,6 2,03 33,37 21,37 
November F453/09 Kidney 181,6 2,03 37,45 21,51 
November F478/09 Kidney 290,5 2,09 28,35 20,87 
November F478/09 Kidney 508,0 2,08 28,01 19,56 
November F478/09 Kidney 529,3 2,05 29,68 20,18 
November F478/09 Kidney 482,6 2,07 31,07 20,59 
November F482/09 Kidney 444,9 1,99 25,78 22,02 
November F482/09 Kidney 146,4 1,99 25,66 21,99 
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Table 28 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). PGI 2009 NVIH. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct-value 
EF1A 
Ct-value 
February 3480 Multiorgan 254,2 2,02 43,3 23,49 
March 3623,1 Multiorgan 205,3 2,05 Neg. 22,36 
March 3623,2 Multiorgan 82,2 2,02 Neg. 22,10 
April 6981,1 Multiorgan 92,3 1,88 Neg. 23,53 
April 6983,1,1,1 Multiorgan 497,0 2,07 Neg. 23,21 
April 6983,1,2,1 Multiorgan 20,9 2,26 Neg. 25,13 
April 6983,1,3,1 Multiorgan 176,2 1,89 Neg. 23,23 
September 14574,2,1 Multiorgan 174,7 2,01 Neg. 22,03 
September 14574,2,2 Multiorgan 124,7 2,00 Neg. 22,32 
September 14574,3,1 Multiorgan 102,1 2,03 Neg. 22,34 
September 14574,5,1 Multiorgan 107,9 2,02 Neg. 22,29 
 October 15833,1 Multiorgan 360,6 2,03 Neg. 21,71 
October 15835,1 Multiorgan 621,9 1,92 Neg. 22,14 
October 18989,1 Multiorgan 700,7 2,09 Neg. 20,28 
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Table 29 – Fish individual data, purification data (NAC and 260/208 ratio), Ct- values of targeting gene from D. 
lepeophtherii (NUC ) and Ct- values from housekeeping gene (EF1A). Autumn disease 2008 NVIB. 
 
Sampling 
month 
Code Organ NAC 260/280-
ratio 
NUC 
Ct- value 
EF1A 
Ct-value 
September F379/08 Kidney 358,1 2,03 26,92 23,41 
September F379/08 Kidney 237,5 2,03 17,86 23,41 
September F379/08 Kidney 237,1 2,04 21,06 23,38 
September F379/08 Kidney 400,4 2,02 22,87 22,08 
September F376/08 Kidney 110,9 1,93 16,52 24,26 
September F376/08 Kidney 272,0 1,97 18,47 23,01 
September F376/08 Kidney 265,8 1,92 17,25 22,55 
September F376/08 Kidney 273,9 1,92 16,91 23,12 
September F380/08 Kidney 649,0 2,00 26,93 23,34 
September F380/08 Kidney 377,1 2,02 25,28 24,41 
September F380/08 Kidney 384,2 2,04 27,13 22,78 
September F380/08 Kidney 414,1 2,01 26,35 23,45 
September F393/08 Kidney 616,3 1,97 16,98 24,28 
September F393/08 Kidney 478,9 1,91 18,95 23,03 
September F393/08 Kidney 294,2 1,98 17,10 22,62 
September F393/08 Kidney 464,3 1,97 18,49 23,78 
October F398/08 Kidney 282,9 2,02 26,18 23,53 
October F398/08 Kidney 215,7 1,99 27,28 23,71 
October F398/08 Kidney 468,4 1,96 29,32 23,00 
October F398/08 Kidney 488,4 1,93 27,45 23,02 
October F404/08 Kidney 411,8 1,99 23,63 22,45 
October F404/08 Kidney 290,2 1,99 19,67 22,84 
October F404/08 Kidney 505,0 1,95 17,42 22,52 
October F404/08 Kidney 900,4 1,95 34,19 25,70 
October F419/08 Kidney 347,3 2,06 22,88 21,91 
October F419/08 Kidney 418,8 1,98 15,79 21,95 
October F419/08 Kidney 452,9 1,98 24,05 22,02 
October F419/08 Kidney 276,6 2,05 16,09 22,46 
 
 
